Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular Carcinoma

Chun Wei Huang, Tsung Han Wu, Heng Yuan Hsu, Kuang Tse Pan, Chao Wei Lee, Sio Wai Chong, Song Fong Huang, Sey En Lin, Ming Chin Yu, Shen Ming Chen

研究成果: 雜誌貢獻文章同行評審

8 引文 斯高帕斯(Scopus)


Background: Alkaline phosphatase (ALP) is a marker of liver function and is associated with biliary tract disease. It was reported as a prognostic factor for hepatocellular carcinoma (HCC). The genetic expression in tumor-tissue microarrays and the perioperative serologic changes in ALP have never been studied for their correlation with HCC prognosis. Methods: The genetic expression of ALP isoforms (placental (ALPP), intestinal (ALPI) and bone/kidney/liver (ALPL)) was analyzed in tumor and non-cancerous areas in 38 patients with HCC after partial hepatectomy. The perioperative change in ALP was further analyzed in a cohort containing 525 patients with HCC to correlate it with oncologic outcomes. A total of 43 HCC patients were enrolled for a volumetry study after major and minor hepatectomy. Results: The genetic expression of the bone/kidney/liver isoform was specifically and significantly higher in non-cancerous areas than in tumors. Patients with HCC with a higher ALP (>81 U/dL) had significantly more major hepatectomies, vascular invasion, and recurrence. Cox regression analysis showed that gender, major hepatectomies, the presence of satellite lesions, higher grades (III or IV) and perioperative changes in liver function tests were independent prognostic factors for recurrence-free survival, and a postoperative increase in the ALP ratio at postoperative day (POD) 7 vs. POD 0 > 1.46 should be emphasized. A liver regeneration rate more than 1.8 and correlation analysis revealed that the ALP level at POD 7 and 30 was significantly higher and correlated with remnant liver growth. Conclusions: This study demonstrated that the perioperative ALP change was an independent prognostic factor for HCC after partial hepatectomies, and the elevation of ALP represented a functional biomarker for the liver but not an HCC biomarker. The higher regeneration capacity was possibly associated with the elevation of ALP after operation.

期刊Journal of Personalized Medicine
出版狀態已發佈 - 4月 2022

ASJC Scopus subject areas

  • 醫藥(雜項)


深入研究「Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular Carcinoma」主題。共同形成了獨特的指紋。